文献速递急性肾损伤慢性肾脏病

社区获得性急性肾损伤与COVID-19住院幸存者的晚期肾功能障碍

Community-Acquired Acute Kidney Injury and Late Kidney Dysfunction in Survivors of COVID-19 Hospitalization.
PubMed 文献 · Kidney Int Rep · 2025-07-03

该前瞻性队列研究纳入巴西2020年3月至8月期间中重度COVID-19住院幸存者655例,随访至出院后11个月,评估社区获得性急性肾损伤(CA-AKI)和医院获得性急性肾损伤(HA-AKI)与晚期肾功能障碍的关系。结果显示CA-AKI而非HA-AKI与晚期肾功能障碍独立相关(aOR=7.3,95%CI:3.6-15.8)。

要点

  • COVID-19住院幸存者中晚期肾功能障碍发生率为28%。
  • CA-AKI与晚期肾功能障碍独立相关(aOR=7.3,95%CI:3.6-15.8)。
  • HA-AKI与晚期肾功能障碍无独立关联(aOR=2.2,95%CI:0.9-4.8)。

核心结论

  • 晚期肾功能障碍影响1/4的COVID-19幸存者。
  • CA-AKI而非HA-AKI是晚期肾功能障碍的独立危险因素。
  • 研究提示肾脏长期COVID可能常见,且特定AKI表型(CA-AKI)可能在其发生中起关键作用。
  • 研究强调需要预防CA-AKI以及对COVID-19感染期间发生该AKI表型的患者进行长期随访和照护。

研究设计与样本

  • 前瞻性队列研究,纳入巴西2020年3月至8月期间中重度COVID-19住院幸存者。
  • 患者出院后随访至11个月。
  • 暴露因素为CA-AKI和HA-AKI。
  • 主要结局为肾功能障碍,定义为随访时新发低估算肾小球滤过率(eGFR<60 ml/min/1.73 m2)和/或较出院时eGFR下降≥25%。
  • 采用调整的二元逻辑回归分析。

主要发现

  • 共评估655例幸存者,随访6.5±1.9个月。
  • 79%发生AKI(35%为CA-AKI,43%为HA-AKI);14%使用肾脏替代治疗(KRT)。
  • 晚期肾功能障碍发生于28%的患者(16%为新发低eGFR,27%为eGFR下降≥25%)。
  • CA-AKI与晚期肾功能障碍独立相关(aOR=7.3,95%CI:3.6-15.8)。
  • HA-AKI与晚期肾功能障碍无独立关联(aOR=2.2,95%CI:0.9-4.8)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Data on the incidence and risk factors for renal long COVID are scarce. We aimed to investigate 2 acute kidney injury (AKI) phenotypes, namely community-acquired (CA; CA-AKI) and hospital-acquired (HA; HA-AKI), and the development of late kidney dysfunction in survivors of COVID-19 hospitalization. METHODS: This is a prospective cohort study of survivors of moderate-to-severe COVID-19 hospitalization in Brazil, from March to August 2020. The patients were assessed for up to 11 months after hospital discharge. Exposure was CA-AKI and HA-AKI. The main outcome was kidney dysfunction defined as incident low estimated glomerular filtration rate (eGFR; < 60 ml/min per 1.73 m2) and/or eGFR decline ≥ 25% from discharge at follow-up. An adjusted binary logistic regression analysis was run. RESULTS: A total of 655 survivors were evaluated (6.5 ± 1.9 follow-up months); 79% had AKI (35% CA and 43% HA); 14% used kidney replacement therapy (KRT). Late kidney dysfunction occurred in 28% of the patients (16% with incident low eGFR and 27% with eGFR decline ≥ 25%). CA-AKI, but not HA-AKI, was independently associated with late kidney dysfunction (adjusted odds ratio [aOR] = 7.3, 95% confidence interval (CI): 3.6-15.8 and aOR = 2.2, 95% CI: 0.9-4.8, respectively). CONCLUSION: In conclusion, late kidney dysfunction affected 1 in 4 COVID-19 survivors. CA-AKI, but not HA-AKI, was an independent risk factor for late kidney dysfunction. These findings suggest that renal long COVID might be frequent and that a specific AKI phenotype (CA-AKI) may play a crucial role in its development. Our research highlights the need for CA-AKI prevention and for the long-term follow-up and care of patients affected by this AKI phenotype during COVID-19 infection.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Ribeiro HS, Frediani MM, Marçal L, et al. Community-Acquired Acute Kidney Injury and Late Kidney Dysfunction in Survivors of COVID-19 Hospitalization. Kidney Int Rep. 2025. PMID: 40980657. doi:10.1016/j.ekir.2025.06.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。